BACK TO CBER — Dr. Vinay Prasad has returned to the FDA’s Center for Biologics Evaluation and Research, leaving industry and ...

The Global Virus Network (GVN), a coalition of leading human and animal virologists from 80+ Centers of Excellence and ...

Shares of Arcturus Therapeutics Holdings climbed after posting a second-quarter loss and revenue that beat analyst expectations. Shares surged 29% to $13.69 Tuesday. The stock is down 13% this year.